Skip to main content
LLY
NYSE Life Sciences

EU Regulators Recommend Lilly's Jaypirca for Broad CLL Approval

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1,124.95
Mkt Cap
$1.062T
52W Low
$623.78
52W High
$1,182.73
52W Position info
80% above low
Off High info
4.9% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

LLY sits 80% above its 52-week low of $623.78.

Summary

The CHMP has recommended Eli Lilly's Jaypirca for approval in the European Union for adults with Chronic Lymphocytic Leukemia (CLL) across all lines of therapy. This is a significant positive regulatory step, paving the way for full EU market access for this new oncology drug. A final decision from the European Commission is expected within one to two months. Lilly has also submitted Jaypirca for FDA approval in CLL, with a decision anticipated in the second half of 2026.

At the time of this announcement, LLY was trading at $1,124.95 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.1T. The 52-week trading range was $623.78 to $1,182.73. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

LLY - Latest Insights

LLY
Nov 17, 2026, 11:18 AM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $1,416.23
Real-time Price: $1,406.35 info
Change: -$9.88 (-0.70%) info
Market Cap: $1.332T info
LLY
Nov 16, 2026, 6:52 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,455.36
Real-time Price: $1,406.35 info
Change: -$49.01 (-3%) info
Market Cap: $1.332T info
LLY
Nov 12, 2026, 8:30 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $1,452.70
Real-time Price: $1,406.35 info
Change: -$46.35 (-3%) info
Market Cap: $1.332T info
LLY
Nov 12, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $1,447.85
Real-time Price: $1,406.35 info
Change: -$41.50 (-3%) info
Market Cap: $1.332T info
LLY
Nov 10, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $1,411.12
Real-time Price: $1,406.35 info
Change: -$4.77 (-0.34%) info
Market Cap: $1.332T info